Detalhe da pesquisa
1.
STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors.
Mol Cancer Ther
; 21(2): 282-293, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34815361
2.
Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer.
J Med Chem
; 65(7): 5675-5689, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332774
3.
Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 Inhibitors.
SLAS Discov
; 26(1): 88-99, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32844715
4.
Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function.
PLoS One
; 15(12): e0243145, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270695
5.
An orally available non-nucleotide STING agonist with antitumor activity.
Science
; 369(6506)2020 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820094
6.
Characterization of murine CEACAM1 in vivo reveals low expression on CD8+ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1.
Oncotarget
; 9(77): 34459-34470, 2018 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30349641
7.
Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma.
Cancer Discov
; 4(10): 1154-67, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25104330
8.
Inhibition of tumor growth progression by antiandrogens and mTOR inhibitor in a Pten-deficient mouse model of prostate cancer.
Cancer Res
; 69(18): 7466-72, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19738074